Clinical trial

Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure

NCT04385589

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-05-01

PhasePHASE4

Study timeline

Study start (actual)2020-05-01Date precision: day

Registry last updated2022-02-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

DapagliflozinDRUG · verified · RxNorm: dapagliflozin

insulinDRUG

Sponsors & collaborators

Assiut Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04385589 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.